Literature DB >> 2430046

Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses.

A P Albino, A N Houghton, M Eisinger, J S Lee, R R Kantor, A I Oliff, L J Old.   

Abstract

Human melanocytes infected with Ki-MSV or Ha-MSV, but not amphotropic MuLV, undergo a series of transformation-related changes that are characteristic of malignant melanoma. These are (a) expression of Ia antigens, in particular DP, DQ, and DR class II histocompatibility gene products, (b) a transformed morphology and ability to grow in soft agar, and (c) a 5-10-fold increase in the cell surface expression of GD3 ganglioside. However, other characteristics of melanoma, such as independence from specific growth factors and loss of adenosine deaminase binding protein were not observed. We conclude that viral ras oncogenes initiate early transformation events in melanocytes, and that Ia antigen expression is a transformation marker in this system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430046      PMCID: PMC2188468          DOI: 10.1084/jem.164.5.1710

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1-sensitive and resistant cell cultures.

Authors:  T Pincus; J W Hartley; W P Rowe
Journal:  Virology       Date:  1975-06       Impact factor: 3.616

2.  Occurrence of Ia antigens on tissues on non-lymphoid origin.

Authors:  K Wiman; B Curman; U Forsum; L Klareskog; U Malmnäs-Tjernlund; L Rask; L Trägårdh; P A Peterson
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

3.  The tyrosine hydroxylase activity of mammalian tyrosinase.

Authors:  S H Pomerantz
Journal:  J Biol Chem       Date:  1966-01-10       Impact factor: 5.157

4.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.

Authors:  S I Shin; V H Freedman; R Risser; R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

6.  Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity.

Authors:  N C Dracopoli; A N Houghton; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

7.  p21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation.

Authors:  T Y Shih; M O Weeks; H A Young; E M Scolnick
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

8.  Expression of Ia-like antigens on cultured human malignant melanoma cell lines.

Authors:  R J Winchester; C Y Wang; A Gibofsky; H G Kunkel; K O Lloyd; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

9.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

10.  DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization.

Authors:  B S Wilson; F Indiveri; M A Pellegrino; S Ferrone
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

View more
  18 in total

1.  Human cervical epithelial cells that express HLA-DR associated with viral infection and activated mononuclear cell infiltrate.

Authors:  S Fais; F Delle Fratte; F Mancini; V Cioni; M Guadagno; G Vetrano; F Pallone
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

Review 2.  Genetics of HLA class II regulation.

Authors:  C R Hume; J S Lee
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes.

Authors:  C R Hume; R S Accolla; J S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  DNA content and MHC class II antigen expression in malignant melanoma: clinical course.

Authors:  J Zaloudik; M Moore; A K Ghosh; Z Mechl; A Rejthar
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

5.  No evidence for xenotropic murine leukemia-related virus infection in Sweden using internally controlled multiepitope suspension array serology.

Authors:  Jonas Blomberg; Fredrik Blomberg; Anna Sjösten; Ali Sheikholvaezin; Agnes Bölin-Wiener; Amal Elfaitouri; Sanna Hessel; Carl-Gerhard Gottfries; Olof Zachrisson; Christina Ohrmalm; Magnus Jobs; Rüdiger Pipkorn
Journal:  Clin Vaccine Immunol       Date:  2012-07-11

6.  HLA-DR antigen expression on melanoma metastases and the course of the disease.

Authors:  M Munzarová; D Zemanová; A Rejthar; Z Mechl; V Kolcová
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

Review 8.  Antigens of melanocytes and melanoma.

Authors:  S A Lynch; B N Bouchard; S Vijayasaradhi; H Yuasa; A N Houghton
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

9.  Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.

Authors:  F Ruiz-Cabello; M A Lopez Nevot; J Gutierrez; M R Oliva; C Romero; A Ferron; F Esteban; C Huelin; M A Piris; C Rivas
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

10.  Sequential changes in MHC antigen expression induced by the v-Ki-ras oncogene.

Authors:  R L Darley; A G Morris
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.